Literature DB >> 10414595

Changes in concanavalin A-reactive proteins in neurological disorders.

L Saso1, G Valentini, M G Leone, E Grippa, R Guglielmi, L Paris, G Cantore, B Silvestrini.   

Abstract

Changes of glycosylation of cerebrospinal fluid proteins such as alpha2-macroglobulin, and prostaglandin D synthase were studied by lectin blotting, using concanavalinA, in multiple sclerosis (n = 42) and neuropathies (n = 20) in comparison to neurological controls (n = 22). The concanavalinA-reactivity of alpha2-macroglobulin, which was increased in the neuropathies but not in multiple sclerosis compared to controls, correlated with the total concanavalinA-reactivity in controls and neuropathies but not in multiple sclerosis, indicating that the protein could be abnormally glycosylated in the latter disease. Although the concentration and the concanavalinA-reactivity of prostaglandin D synthase were not significantly different in the three groups, the two parameters correlated only in neuropathies but not in controls or multiple sclerosis, probably due to the high heterogeneity of the protein. These changes deserve to be studied in further detail in view of their potential clinical applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414595      PMCID: PMC6807750          DOI: 10.1002/(sici)1098-2825(1999)13:4<158::aid-jcla4>3.0.co;2-0

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  43 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Biotechnology       Date:  1992

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Abnormalities in native and dissociated alpha 2-macroglobulin isolated from multiple sclerosis serum.

Authors:  S C Rastogi; J Clausen
Journal:  Clin Chim Acta       Date:  1980-10-23       Impact factor: 3.786

4.  Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

5.  Abnormal serum alpha 2-macroglobulin in multiple sclerosis.

Authors:  S C Rastogi; J Clausen; T Fog
Journal:  Eur Neurol       Date:  1981       Impact factor: 1.710

6.  Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus.

Authors:  A Mackiewicz; R Marcinkowska-Pieta; S Ballou; S Mackiewicz; I Kushner
Journal:  Arthritis Rheum       Date:  1987-05

7.  Micropurification of two human cerebrospinal fluid proteins by high performance electrophoresis chromatography.

Authors:  M G Leone; L Saso; A Del Vecchio; M Y Mo; B Silvestrini; C Y Cheng
Journal:  J Neurochem       Date:  1993-08       Impact factor: 5.372

8.  Microheterogeneity of CSF alpha 2-macroglobulin in multiple sclerosis and other neurological diseases. A study performed by direct immunofixation after isoelectric focusing.

Authors:  P Mazzarello; M Poloni; P Pinelli
Journal:  Acta Neurol Belg       Date:  1985 Aug-Oct       Impact factor: 2.396

9.  Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit.

Authors:  L Saso; B Silvestrini; I Zwain; A Guglielmotti; M R Luparini; V Cioli; C Y Cheng
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

10.  'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid.

Authors:  A Hoffmann; M Nimtz; R Getzlaff; H S Conradt
Journal:  FEBS Lett       Date:  1995-02-13       Impact factor: 4.124

View more
  1 in total

1.  Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis.

Authors:  A Croce; O Firuzi; F Altieri; M Eufemi; R Agostino; R Priori; M Bombardieri; C Alessandri; G Valesini; L Saso
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.